# The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination

> **NCT03194555** · PHASE2 · COMPLETED · sponsor: **Allodynic Therapeutics, Inc** · enrollment: 12 (actual)

## Conditions studied

- Migraine With or Without Aura

## Interventions

- **DRUG:** Low-Dose Naltrexone and Acetaminophen Combination
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03194555
- **Lead sponsor:** Allodynic Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-25
- **Primary completion:** 2018-07-26
- **Final completion:** 2018-07-28
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03194555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03194555, "The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03194555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*